4//SEC Filing
Kaufman Arik 4
Accession 0001213900-20-014424
CIK 0001211805other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 5:53 PM ET
Size
17.6 KB
Accession
0001213900-20-014424
Insider Transaction Report
Form 4
My Size, Inc.MYSZ
Kaufman Arik
Director
Transactions
- Disposition to Issuer
Option to purchase Common Stock (right to buy)
2020-05-25−667→ 0 totalExercise: $18.15Exp: 2022-07-24→ Common Stock, $.001 par value per share (667 underlying) - Award
Option to purchase Common Stock (right to buy)
2020-05-25+667→ 667 totalExercise: $1.04Exp: 2024-09-06→ Common Stock, $.001 par value per share (667 underlying) - Disposition to Issuer
Option to purchase Common Stock (right to buy)
2020-05-25−667→ 0 totalExercise: $13.65Exp: 2023-09-06→ Common Stock, $.001 par value per share (667 underlying) - Disposition to Issuer
Option to purchase Common Stock (right to buy)
2020-05-25−1,000→ 0 totalExercise: $11.40Exp: 2024-05-29→ Common Stock, $.001 par value per share (1,000 underlying) - Award
Option to purchase Common Stock (right to buy)
2020-05-25+667→ 667 totalExercise: $1.04Exp: 2023-07-24→ Common Stock, $.001 par value per share (667 underlying) - Award
Option to purchase Common Stock (right to buy)
2020-05-25+1,000→ 1,000 totalExercise: $1.04Exp: 2025-05-29→ Common Stock, $.001 par value per share (1,000 underlying)
Footnotes (4)
- [F1]Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested.
- [F2]Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of July 24, 2023. All of the other terms of the option remained unchanged.
- [F3]Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of September 6, 2024. All of the other terms of the option remained unchanged.
- [F4]Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged.
Documents
Issuer
My Size, Inc.
CIK 0001211805
Entity typeother
Related Parties
1- filerCIK 0001713725
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 5:53 PM ET
- Size
- 17.6 KB